Clinical Trial Update: Subcutaneous Progesterone Supplementation in Patients With Endometriosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating subcutaneous progesterone for endometriosis. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Progesterone (subcutaneous) (progesterone)

Snippet

Sponsor: University Magna Graecia | Conditions: Endometriosis | Phase 3 | Status: UNKNOWN